Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains unknown. Here we show that conventional Par-4 knockout (Par-4 ) mice and adipocyte-specific Par-4 knockout (AKO) mice, but not hepatocyte-specific...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology Vol. 12; p. 860446
Main Authors: Araujo, Nathalia, Sledziona, James, Noothi, Sunil K, Burikhanov, Ravshan, Hebbar, Nikhil, Ganguly, Saptadwipa, Shrestha-Bhattarai, Tripti, Zhu, Beibei, Katz, Wendy S, Zhang, Yi, Taylor, Barry S, Liu, Jinze, Chen, Li, Weiss, Heidi L, He, Daheng, Wang, Chi, Morris, Andrew J, Cassis, Lisa A, Nikolova-Karakashian, Mariana, Nagareddy, Prabhakar R, Melander, Olle, Evers, B Mark, Kern, Philip A, Rangnekar, Vivek M
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 29-03-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains unknown. Here we show that conventional Par-4 knockout (Par-4 ) mice and adipocyte-specific Par-4 knockout (AKO) mice, but not hepatocyte-specific Par-4 knockout mice, are obese with standard chow diet. Par-4 and AKO mice exhibit increased absorption and storage of fat in adipocytes. Mechanistically, Par-4 loss is associated with downregulation and activation of p53. We identified complement factor as a p53-regulated gene linked to fat storage in adipocytes. re-expression in adipocytes or deletion reversed the obese mouse phenotype. Moreover, obese human subjects showed lower expression of Par-4 relative to lean subjects, and in longitudinal studies, low baseline Par-4 levels denoted an increased risk of developing obesity later in life. These findings indicate that Par-4 suppresses p53 and its target to regulate obesity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Philipp E. Scherer, University of Texas Southwestern Medical Center, United States; Andreas Prokesch, Medical University of Graz, Austria; Isabel Reinisch, Medical University of Graz, in collaboration with reviewer AP
This article was submitted to Cancer Metabolism, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work and share first authorship
Edited by: Che-Pei Kung, Washington University in St. Louis, United States
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.860446